Trials / Sponsors / Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer Cutaneous Breast Cancer | Phase 2 | 2024-02-12 |
| Completed | Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Express Glioma, Glioblastoma, Glioblastoma Multiforme | Phase 2 | 2017-12-17 |
| Completed | Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurre Glioma, Glioblastoma, Glioblastoma Multiforme | Phase 2 | 2017-01-20 |
| Completed | Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Glioma, Glioblastoma, Glioblastoma Multiforme | Phase 1 / Phase 2 | 2011-10-01 |
| No Longer Available | Expanded Access to VAL-083 Cancer | — | — |